A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

Clinical trial NCT05318976 · COMPLETED

Trial details

NCT number: NCT05318976
Sponsor: Inmune Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders Mild Cognitive Impairment

Start date: 2022-02-28
Primary completion: 2025-05-12
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.